Literature DB >> 4123827

Temperature-dependent variation in the synthesis of group-specific carbohydrate by streptococcal variant strains. I. Immunochemical studies.

E M Ayoub, B A Dudding.   

Abstract

A temperature-dependent alteration in the synthesis of the group-specific polysaccharide was found to occur in two "variant" streptococcal strains, A-486-Var and C 121/46/4. These strains synthesize a polysaccharide with variant immunochemical characteristics when grown at 37 degrees C. However, when these organisms are grown at lower temperatures, 22 degrees C, an enhanced synthesis of Group A carbohydrate occurs. Other variant strains show no appreciable alteration of the cell wall carbohydrate composition when grown at lower temperatures. Studies on an intermediate strain show that this organism has a propensity for the synthesis of a polysaccharide with higher glucosamine content and enhanced Group A serological reactivity when grown at 22 degrees C. Immunochemical studies performed on the carbohydrates produced by the A-486-Var at various temperatures revealed that the appearance of Group A serological reactivity at lower temperatures is due to the additional synthesis of a polysaccharide with Group A specificity along with the continued synthesis of a variant carbohydrate. This finding contrasts with data obtained on the carbohydrate produced by the intermediate organisms that appears to consist predominently of one molecule bearing dual A and variant antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4123827      PMCID: PMC2180548          DOI: 10.1084/jem.138.1.117

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  7 in total

1.  Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains.

Authors:  M McCARTY; R C LANCEFIELD
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

2.  Persistence of streptococcal group A antibody in patients with rheumatic valvular disease.

Authors:  B A Dudding; E M Ayoub
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

3.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

4.  TYPING GROUP A HEMOLYTIC STREPTOCOCCI BY M PRECIPITIN REACTIONS IN CAPILLARY PIPETTES.

Authors:  H F Swift; A T Wilson; R C Lancefield
Journal:  J Exp Med       Date:  1943-08-01       Impact factor: 14.307

5.  Variation in the group-specific carbohydrate of group A streptococci. II. Studies on the chemical basis for serological specificity of the carbohydrates.

Authors:  M MCCARTY
Journal:  J Exp Med       Date:  1956-11-01       Impact factor: 14.307

6.  Further studies on the chemical basis for serological specificity of Group A streptococcal carbohydrate.

Authors:  M McCARTY
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

7.  LOSS OF GROUP CARBOHYDRATE DURING MOUSE PASSAGES OF A GROUP A HEMOLYTIC STREPTOCOCCUS.

Authors:  A T Wilson
Journal:  J Exp Med       Date:  1945-06-01       Impact factor: 14.307

  7 in total
  4 in total

1.  Immunochemical analysis of streptococcal group A, B, and C carbohydrates, with emphasis on group A.

Authors:  J C Fung; K Wicher; M McCarty
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

2.  Temperature-dependent variation in the synthesis of streptococcal group-specific carbohydrate. II. Biosynthetic studies in group A and variant strains.

Authors:  E M Ayoub
Journal:  J Bacteriol       Date:  1978-05       Impact factor: 3.490

3.  Cross-stimulation of monoclonal antibodies in anamnestic responses.

Authors:  M Cramer; D G Braun
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

4.  Studies of the receptor for phage A25 in group A streptococci: the role of peptidoglycan in reversible adsorption.

Authors:  P P Cleary; L W Wannamaker; M Fisher; N Laible
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.